Fresenius GranuFlo and NaturaLyte Dialysis Heart Attack Attorneys

GranuFlo® and NaturaLyte® were recalled in March, 2012, because they carry an elevated risk of causing heart attack and death. Adding insult to injury, for months before the recall the company that makes these deadly products knew about the dangers, and the steps that clinicians should take to protect their patients, but chose not to inform its customer clinic, knowingly leaving thousands of patients at risk. If you have suffered a GranuFlo® or NaturaLyte® heart injury, or lost a loved one to these deadly products, talk to our Massachusetts drug recall attorneys right away.

GranuFlo® & NaturaLyte® Injuries

Hemodialysis is used to replace the function that the kidneys normally perform, in patients with chronic or acute renal failure. GranuFlo® and NaturaLyte® are acid concentrates used in hemodialysis treatment. Fresenius Medical Care (FMC) makes these products and sells them to dialysis clinics throughout the country. The company also operates its own chain of dialysis clinics where its products are used.

GranuFlo® and NaturaLyte® can cause serious, and even fatal, injuries including:

  • Sudden cardiac death
  • Heart attack
  • Cardiopulmonary arrest
  • Stroke
  • Low blood pressure
  • Cardiac arrhythmia
  • Low potassium (hypokalemia)
  • Too little oxygen in the blood (hypoxemia)
  • Too much carbon dioxide in the blood (hypercapnia)

If you believe that your heart attack or cardiac injuries were caused by GranuFlo® or NaturaLyte®, or that the death of a loved one resulted from the use of these products during dialysis treatment, please contact our Massachusetts drug recall attorneys at 1-877-LOSS-RECOVER (567-7732) today. There is a time limit for filing a personal injury or wrongful death lawsuit.

J&J’s Vaginal Mesh Introduced Without US Approval

Johnson & Johnson’s Gynecare Prolift vaginal mesh is the subject of at least 550 injury lawsuits, and it turns out that the device was on the market for three years before it received appropriate clearance from the U.S. Food and Drug Administration (FDA). If you have been injured by J&J vaginal mesh our Massachusetts transvaginal mesh attorneys can help.

Transvaginal mesh is implanted in a woman’s body during surgery to correct pelvic organ prolapse (POP) and stress urinary incontinence (SUI). One of the known dangers of Prolift vaginal mesh is a complication called erosion. One study of the Prolift was cut short because of the high rate of erosion in study subjects.

J&J introduced the Prolift in March, 2005. It did not receive 510(k) clearance for market from the FDA until May, 2008.

New Devices Cleared Based on Defective Devices

510(k) clearance is a fast-track process that gets new medical devices to market very quickly without requiring clinical trials, as long as they are considered “substantially equivalent” to an existing approved device. One of the major flaws with the process is that new devices can be cleared even if they are based on devices which are known to be defective. In fact, the FDA is required to grant clearance, under the current law.

New legislation has been proposed which would give the FDA the power to require device makers to show documentation that they have addressed any known safety issues. The legislation is called the Safety of Untested and New Devices (SOUND) Act.

If you or a loved one has been harmed or killed by defective vaginal mesh and you live in Massachusetts, please contact our Massachusetts drug recall attorneys at 1-877-LOSS-RECOVER (567-7732). Our experienced product liability lawyers will recover the compensation you deserve.

Massachusetts Pradaxa Injury Attorneys

Pradaxa (dabigatran) is a new type of blood thinner prescribed to prevent stroke in people with nonvalvular atrial fibrillation (AFib), and it works. The problem is that the side effects can kill you. If you have been harmed by Pradaxa, please talk to our Massachusetts drug recall attorneys right away.

Dangers of Pradaxa

Dangerous and deadly side effects of Pradaxa can include:

  • Internal bleeding
  • Gastrointestinal bleeding
  • Bleeding in the brain
  • Hemorrhagic stroke
  • Uncontrollable excessive bleeding after injury, even very minor injury
  • Heart attack

Pradaxa Heart Attack

In January, 2012, a study results published in the Archives of Internal Medicine revealed that Pradaxa use increases the risk of heart attack and acute coronary syndrome by 33% when compared to controls which included patients taking warfarin and those taking a placebo.

Pradaxa is Different than other Anticoagulants

All anticoagulants, or blood thinners, can cause serious bleeding events because they prevent the blood from clotting. When blood thinners cause a bleeding event, doctors follow a reversal protocol which quickly gets bleeding under control. This typically includes administering a reversal agent that quickly neutralizes the blood thinning drug, and administering other substances which help the blood start clotting.

This does not work with Pradaxa for several reasons including the fact that there is no reversal agent for Pradaxa. The reversal protocol for Pradaxa takes hours and it is not completely effective. Since it is a new drug, many doctors are not familiar with it and do not know the proper steps to take. Even when they do, it may not work fast enough to save a dying patient.

If you or a loved one has been harmed or killed by Pradaxa and you live in Massachusetts, please contact our Massachusetts drug recall attorneys at 1-877-LOSS-RECOVER (567-7732). Our experienced product liability lawyers will recover the compensation you deserve.